MYX 3.29% $4.40 mayne pharma group limited

Ann: MYX signs license agreement for women's health products, page-109

  1. 883 Posts.
    lightbulb Created with Sketch. 322
    Patrick, stop talking before you read and consider the facts. You have no idea of what a business model looks like. You have no concept of where the directors are going, though it is obvious and practical. Imagine walking into 1600 existing HCP who are prescribing women with Nextstellis and the Ring in your box of tricks. AND vice versa - walking in to MYX HCP's with the extra products. The need for the concentrated visiting of HCP must be because they DONT AUTOMATICALLY KNOW OF WHAT IS AVAILABLE and so good products are wasted unless put in front of their eyes AND SOLD. The Cross Over opportunity is amazing. To be honest, the Ring Product looks amazing - except for the side effects (which won't bother anyone - since most take the vax).
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.